logo
#

Latest news with #advisers

Trump still uses personal phone
Trump still uses personal phone

Russia Today

time6 hours ago

  • General
  • Russia Today

Trump still uses personal phone

US President Donald Trump continues to rely on his personal cellphone, despite repeated warnings from aides and security experts about foreign surveillance risks, The Atlantic reported on Monday. The phone remains Trump's main link to the outside world, connecting him with friends, family, lawmakers, corporate leaders, celebrities, world leaders, and journalists, sources close to the president told the outlet. He also often answers calls from unknown numbers, reportedly viewing them as opportunities for spontaneous conversations, they claim. 'He likes to call people. He likes to be called,' one adviser reportedly said. Another noted that 'probably a ton' of people have Trump's personal number, while a third estimated the figure at 'well over 100.' President Trump at Mar-a-Lago on the phone working. An absolute machine 🔥 Trump reportedly uses multiple devices, with at least one dedicated to social media. Several sources claim Trump often leaves lengthy voicemails and inquires if recipients have shared his messages with relatives and friends. They also claim Trump distrusts White House landlines, fearing eavesdropping by what he sees as the 'deep state.' 'His perspective was, 'I can't trust anyone on the White House staff, so I have to use my cellphone,'' a former adviser told the outlet. Security officials have long warned Trump that personal phones are vulnerable to hacking and wiretapping. In late 2024, the FBI claimed Chinese hackers had breached US telecom networks, allowing them to eavesdrop on calls involving Trump and other political figures. Despite the concerns, the president reportedly dismissed the warnings. 'He'd just reject it and say, 'It's not true,'' a former adviser said. 'He'd say, 'My phone is the best on the market.'' Advisers eventually gave up trying to limit his phone use, the sources claimed, although one said the devices had been upgraded with additional security features. The White House declined to confirm those details. 'We will not discuss or disclose security measures regarding the President, especially to The Atlantic,' Communications Director Steven Cheung told the outlet in an emailed statement. The White House recently had issues with the magazine after an Atlantic editor gained access to an internal chat involving senior Trump officials discussing a strike against the Houthi militants and then writing a story about it. Cheung defended Trump's approach, saying his use of a personal phone makes him 'the most transparent and accessible President in American history.'

Trump Gets a Tariff Reprieve as Advisers Plot Out a Plan B
Trump Gets a Tariff Reprieve as Advisers Plot Out a Plan B

Bloomberg

time5 days ago

  • Business
  • Bloomberg

Trump Gets a Tariff Reprieve as Advisers Plot Out a Plan B

This is Washington Edition, the newsletter about money, power and politics in the nation's capital. Today, Treasury reporter Daniel Flatley looks at the legal battle over the legality of the president's tariffs. Sign up here and follow us at @bpolitics. Email our editors here. The legal wrangling over President Donald Trump's tariffs may have just begun in earnest, with a Supreme Court hearing in the near future, but his advisers left no doubt he'll pursue duties on imports no matter what.

Pfizer Hits FDA Setback in Effort to Boost Prostate Cancer Drug
Pfizer Hits FDA Setback in Effort to Boost Prostate Cancer Drug

Bloomberg

time21-05-2025

  • Business
  • Bloomberg

Pfizer Hits FDA Setback in Effort to Boost Prostate Cancer Drug

Pfizer Inc. failed to convince advisers to the US Food and Drug Administration to support a dramatic expansion in the use of its prostate cancer drug, a setback that could scuttle the company's blockbuster ambitions for the treatment. A group of independent experts voted unanimously that Pfizer didn't present convincing data to broaden the approval of Talzenna, a pill currently cleared for a group of patients with prostate cancer that has specific genetic mutations. The FDA isn't required to follow the votes of its advisers, but typically does.

Succession Planning Among the Super Wealthy Ticks Up
Succession Planning Among the Super Wealthy Ticks Up

Wall Street Journal

time21-05-2025

  • Business
  • Wall Street Journal

Succession Planning Among the Super Wealthy Ticks Up

The percentage of super wealthy families globally that has a will or estate plan in place inched up to 53% this year from 47% a year earlier, a new UBS survey of its family office clients shows, as a decadeslong transfer of wealth from older generations to their heirs picks up steam. The increase is small but notable given the difficulties often associated with succession planning for the wealthy. Advisers to the wealthy say devising a wealth-transfer plan can require people to take stock of their mortality, develop a sense of the legacy they want to leave behind and also have a good understanding of the capabilities of any heirs.

Roche Needs More US Data on Key Cancer Drug, FDA Advisers Say
Roche Needs More US Data on Key Cancer Drug, FDA Advisers Say

Bloomberg

time20-05-2025

  • Health
  • Bloomberg

Roche Needs More US Data on Key Cancer Drug, FDA Advisers Say

A group of advisers to the Food and Drug Administration said Roche Holding AG needs to study its blood cancer treatment in more American patients before its use can be expanded. Independent experts voted eight-to-one that the results of a pivotal Roche trial, which enrolled just 9% of its total patients from the US, weren't applicable to the domestic population. They asked the Swiss company to gather more data. Roche said in a statement it would continue working with the FDA on a regulatory path forward.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store